Summary: Predictive diagnostics for personalized medicine.
Additional Information: Tethys Bioscience is a predictive personalized medicine company developing novel tests which address the growing global healthcare challenge of chronic diseases such as diabetes. Founded in 2005, the company integrates an experienced management team, innovative research based on sound science, a CLIA-licensed clinical laboratory, and a commercialization team with extensive experience in diagnostic innovation. Our partnerships with world class researchers and our solid financial foundation will enable Tethys to help transform the management of chronic diseases by providing personalized, preventive solutions that aid every constituency: patients, doctors and the healthcare system as a whole.
Lipomics Technologies makes advances in metabolomics. - DFJ Frontier portfolio company Lipomics Technologies making news as metabolomics emerge as a significant player in the drug development arena. Genetic Engineering News,
Feb 15, 2006.